BIIO Stock Overview
A medical device company, focuses on developing automated treatment for age spots.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bionovate Technologies Corp Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIIO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 1.6% |
| 1Y | n/a | 20.6% | 30.5% |
Return vs Industry: Insufficient data to determine how BIIO performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how BIIO performed against the US Market.
Price Volatility
| BIIO volatility | |
|---|---|
| BIIO Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BIIO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BIIO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Timothy Jones | bionovate.com |
Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide.
Bionovate Technologies Corp Fundamentals Summary
| BIIO fundamental statistics | |
|---|---|
| Market cap | US$7.00 |
| Earnings (TTM) | -US$105.31k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs BIIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIIO income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$105.31k |
| Earnings | -US$105.31k |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BIIO perform over the long term?
See historical performance and comparison